ENTRY       D12509                      Drug
NAME        Trontinemab (USAN/INN)
FORMULA     C8602H13332N2310O2719S56
EXACT_MASS  194288.0331
MOL_WEIGHT  194407.3831
SEQUENCE    (Heavy chain)
            GNTHKPYGYV RYFDVWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVEDYFP
            EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV
            DEKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP
            EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP
            IEKTISKAKG QPREPQVYTL PPCRDELTKN QVSLWCLVKG FYPSDIAVEW ESNGQPENNY
            KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGGGSGG
            GGSGGGGSGG GGSQSMQESG PGLVKPSQTL SLTCTVSGFS LSSYAMSWIR QHPGKGLEWI
            GYIWSGGSTD YASWAKSRVT ISKTSTTVSL KLSSVTAADT AVYYCARRYG TSYPDYGDAS
            GFDPWGQGTL VTVSSASVAA PSVFIFPPSD EQLKSGTASV VCLLNNFYPR EAKVQWKVDN
            ALQSGNSQES VTEQDSKDST YSLSSTLTLS KADYEKHKVY ACEVTHQGLS SPVTKSFNRG
            EC
            (heavy chain)
            QVELVESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSA INASGTRTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARGK GNTHKPYGYV RYFDVWGQGT
            LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVEDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DEKVEPKSCD KTHTCPPCPA
            PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP
            REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVCTL
            PPSRDELTKN QVSLSCAVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLVSKLT
            VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            AIQLTQSPSS LSASVGDRVT ITCRASQSIS SYLAWYQQKP GKAPKLLIYR ASTLASGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ NYASSNVDNT FGGGTKVEIK SSASTKGPSV
            FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV
            VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSC
            (light chain)
            DIVLTQSPAT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGVP
            ARFSGSGSGT DFTLTISSLE PEDFATYYCL QIYNMPITFG QGTKVEIKRT VAAPSVFIFP
            PSDRKLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H153-H209, H229-L215, H235-h235, H238-h238, H270-H330, H376-H434, H363-H358, H494-H565, H622-H682, H702-l215, h22-h96, h153-h209, h229-l'215, h270-h330, h376-h434, L23-L88, L139-L195, l23-l89, l135-l195, l'23-l'89, l'135-l'195)
  TYPE      Peptide
EFFICACY    Dementia therapeutic agent
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of Alzheimer's disease
TARGET      Amyloid beta [CPD:C16514 C16515]
            TFRC (CD71) [HSA:7037] [KO:K06503]
  PATHWAY   hsa04066(7037)  HIF-1 signaling pathway
            hsa04144(7037)  Endocytosis
            hsa04145(7037)  Phagosome
            hsa04216(7037)  Ferroptosis
            hsa04640(7037)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                TFRC (CD71)
                 D12509  Trontinemab (USAN/INN)
DBLINKS     CAS: 2568868-35-7
///
